Press release

The ISREC Foundation and Two Private Foundations Based in Lausanne Finance a Pioneering Clinical Trial for Leukemia at the CHUV.
In an innovative collaborative approach, the ISREC Foundation is managing the funding of a clinical immunotherapy trial to be conducted at the CHUV. This project, which aims to develop a treatment for children and adults with acute leukemia, is funded through 2.8 million CHF in donations. Thanks to this collaboration, two private foundations can join forces to support translational cancer research and ensure professional scientific monitoring.